Psychopharmacology update: why choose quetiapine for bipolar illness?
Tobin
Mary L
ML
D014150:Antipsychotic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001714:Bipolar Disorder / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D003987:Dibenzothiazepines / Q000494:pharmacology / Q000627:therapeutic use*; D017277:Drug Approval; D016903:Drug Monitoring / Q000451:nursing; D006801:Humans; D009730:Nursing Assessment; D018579:Patient Selection; D011600:Psychopharmacology; D000069348:Quetiapine Fumarate; D012307:Risk Factors; D013997:Time Factors; D016896:Treatment Outcome; D014481:United States; D014486:United States Food and Drug Administration
D014150:Antipsychotic Agents; D003987:Dibenzothiazepines; D000069348:Quetiapine Fumarate